baito logo
    navigation?.buttons?.createJob?.text
    BIOMERIEUX header
    BIOMERIEUX logo
    #invitrodiagnostik #klinischediagnostik #mikrobiologie

    BIOMERIEUX

    from Marcy-l'Étoile

    bioMérieux is a global leader in In-Vitro Diagnostics, providing innovative solutions for clinical and industrial applications. With over 14,600 employees, it is committed to patient health and is dedicated to sustainability and social responsibility.

    Visit website

    bioMérieux: A Pioneer in In-Vitro Diagnostics

    bioMérieux is a global leader in the field of In-Vitro Diagnostics. Founded in 1897 by Marcel Mérieux, the company has evolved into a family-owned business that has specialized in the development, production, and distribution of diagnostic solutions for over 60 years. These solutions include reagents, devices, software, and services for medical and industrial applications.

    Key Products and Services

    • Clinical Diagnostics: bioMérieux offers comprehensive solutions for the diagnosis of infectious diseases, cardiovascular diseases, and cancers. A particular focus is on combating antimicrobial resistance (AMR), with three-quarters of the research and development work and 80% of the product portfolio aimed at AMR[3].
    • Industrial Diagnostics: The company is a leader in industrial microbiology and provides solutions for the food, cosmetics, and pharmaceutical industries for microbiological quality control[2].

    Mission and Values

    The mission of bioMérieux is to protect and improve the health of patients and consumers worldwide. The company is committed to providing high-quality, innovative products and services to identify causes of diseases and sources of contamination, and to meet the needs of laboratories and clinics[2].

    Sustainability Goals and Initiatives

    bioMérieux is engaged in various social and environmental initiatives. The company emphasizes the importance of global partnerships to promote public health and supports local communities through various programs, such as food collection for the needy or support for educational initiatives[4].

    International Presence

    bioMérieux is present in over 160 countries and has an extensive distribution network. The company has offices in 45 countries and is listed on Euronext Paris[2][4]. With a revenue of over 3.1 billion euros in 2020 and more than 90% of sales outside France, bioMérieux demonstrates its strong global orientation[4].

    Employees and Growth

    By the end of 2023, bioMérieux employed over 14,600 people worldwide[1]. The company is committed to continuous growth and innovation, as evidenced by the recent acquisition of SpinChip Diagnostics, a Norwegian diagnostics start-up that develops innovative immunoassays[4].

    Sources: